- Home
- BCH vs WST Comparison
BCH vs WST Comparison
Compare BCH & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCH
- WST
- Stock Information
- Founded
- BCH 1893
- WST 1923
- Country
- BCH Chile
- WST United States
- Employees
- BCH N/A
- WST N/A
- Industry
- BCH Commercial Banks
- WST Medical/Dental Instruments
- Sector
- BCH Finance
- WST Health Care
- Exchange
- BCH Nasdaq
- WST Nasdaq
- Market Cap
- BCH 15.7B
- WST 15.6B
- IPO Year
- BCH 2002
- WST N/A
- Fundamental
- Price
- BCH $29.39
- WST $215.84
- Analyst Decision
- BCH Hold
- WST Strong Buy
- Analyst Count
- BCH 1
- WST 6
- Target Price
- BCH $23.00
- WST $349.00
- AVG Volume (30 Days)
- BCH 291.3K
- WST 587.7K
- Earning Date
- BCH 07-29-2025
- WST 07-24-2025
- Dividend Yield
- BCH 7.15%
- WST 0.39%
- EPS Growth
- BCH N/A
- WST N/A
- EPS
- BCH 0.01
- WST 6.37
- Revenue
- BCH $2,816,160,332.00
- WST $2,895,800,000.00
- Revenue This Year
- BCH $19.17
- WST $3.38
- Revenue Next Year
- BCH $4.84
- WST $5.85
- P/E Ratio
- BCH $11.56
- WST $34.09
- Revenue Growth
- BCH N/A
- WST N/A
- 52 Week Low
- BCH $22.06
- WST $187.43
- 52 Week High
- BCH $31.84
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- BCH 40.16
- WST 48.07
- Support Level
- BCH $30.02
- WST $221.02
- Resistance Level
- BCH $31.36
- WST $230.27
- Average True Range (ATR)
- BCH 0.59
- WST 5.73
- MACD
- BCH -0.19
- WST -0.20
- Stochastic Oscillator
- BCH 2.89
- WST 40.05
About BCH Banco De Chile ADS
Operating under three separate brand names (Banco de Chile, Banco Edwards-Citi, and Banco CrediChile) Banco de Chile is the second largest in the country by loans and third largest by deposits. Banco de Chile generates most of its net interest income (roughly 60% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans, with 25% of its outstanding loans being made to firms with more than 10,000 million CLP in revenue. Outside of its banking business, Banco de Chile is the largest asset manager in the country and one of the largest security brokerages, supporting its substantial fee-based revenue.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.